The WACC of scPharmaceuticals Inc (SCPH) is 7.7%.
Range | Selected | |
Cost of equity | 5.7% - 9.6% | 7.65% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 7.0% - 14.3% | 10.65% |
WACC | 5.6% - 9.8% | 7.7% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.41 | 0.85 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.7% | 9.6% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.25 | 0.25 |
Cost of debt | 7.0% | 14.3% |
After-tax WACC | 5.6% | 9.8% |
Selected WACC | 7.7% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
SCPH | scPharmaceuticals Inc | 0.25 | 1.74 | 1.47 |
ACRX | AcelRx Pharmaceuticals Inc | 0.4 | 1.74 | 1.35 |
BMY | Bristol-Myers Squibb Co | 0.53 | 0.15 | 0.1 |
EBM.V | Eastwood Bio-Medical Canada Inc | 0 | -1.45 | -1.44 |
ETON | Eton Pharmaceuticals Inc | 0.08 | 1.11 | 1.05 |
JNJ | Johnson & Johnson | 0.1 | 0.09 | 0.08 |
PCLO.V | Pharmacielo Ltd | 1.62 | -2.03 | -0.93 |
ROMJ.V | Rubicon Organics Inc | 0.35 | -1.16 | -0.92 |
SCYX | SCYNEXIS Inc | 0.51 | 1.21 | 0.89 |
XLY.V | Auxly Cannabis Group Inc | 0.58 | 0.72 | 0.51 |
Low | High | |
Unlevered beta | 0.1 | 0.66 |
Relevered beta | 0.12 | 0.78 |
Adjusted relevered beta | 0.41 | 0.85 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for SCPH:
cost_of_equity (7.65%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.41) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.